Anti-Factor Xa Test results in <15 minutes directly from 50 µL whole blood Heparin dosing requires tight and timely control to prevent both bleeding and clotting complications. Anti-Factor Xa tests are confined to central labs and often take over an hour, delaying time-sensitive dosing. Designed for patients receiving unfractionated or low molecular weight heparin, the FINDER® Anti-Factor Xa Test delivers results in <15 minutes from just a 50 µL drop of whole blood. By enabling heparin monitoring at the point of care, FINDER helps clinicians optimize dosing quickly and effectively in critical care settings. *Baebies Early Access Program offers select clinical partners an opportunity to evaluate the FINDER Anti-Factor Xa Test. Join a growing list of top hospitals shaping the future of point-of-care testing. No Centrifugation Needed Anti-Factor Xa test results directly from 50 µL of whole blood Ultra-rapid Results Delivers positive results in <15 minutes right at the point-of-care Intuitive 3-Step Workflow No specialized training required and minimal hands-on time Novel Fluorogenic Substrate Overcome chromogenic substrate’s spectral interference with bilirubin and hemoglobin Hybrid Calibration Engineered to measure both Unfractionated Heparin and Low Molecular Weight Heparin Built-In Quality Controls Over 100 integrity checkpoints on-cartridge to ensure reliable results Read Further:
Any test. Anywhere. Everyone.™
FDA Breakthrough Designation for First Point-of-Care Heparin Monitoring Test
FINDER Utilizes Digital Microfluidics to Deliver:
Intuitive Workflow in 4 Simple Steps
Info@baebies.com
Call us: +1 (919) 891-0432
